Nafamostat Mesylate Monotherapy in Patients with Moderate COVID-19: a Single-Center, Retrospective Study
Soma et al., Japanese Journal of Infectious Diseases, doi:10.7883/yoken.JJID.2021.699
https://c19early.org/soma.html